Utility of PET/CT in differentiating benign from malignant adrenal nodules in patients with cancer

American Journal of Roentgenology

Volumn 191, Issue 5, 2008, Pages 1545-1551

  Vikram, Raghunandan ^a   Yeung, Henry D W ^b   Macapinlac, Homer A ^a   Iyer, Revathy B ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

Author keywords

Adrenal gland; Malignancy; Metastasis; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADRENAL CANCER; ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER SIZE; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SKIN BIOPSY; SKIN NODULE;

ADRENAL GLAND NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 55549100243     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.07.3447     Document Type: Article

References (33)

1. Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma: analysis of 1000 autopsied cases. Cancer 1950; 3:74-85
2. Copeland PM. The incidentally discovered adrenal mass. Ann Intern Med 1983; 98:940-945
3. Chong S, Lee KS, Kim HY, et al. Integrated PETCT for the characterization of adrenal gland lesions in cancer patients: diagnostic efficacy and interpretation pitfalls. RadioGraphics 2006; 26:1811-1824
4. Boland GW, Lee MJ, Gazelle GS, Halpern EF, McNicholas MM, Mueller PR. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR 1998; 171:201-204
5. Korobkin M, Brodeur FJ, Francis IR, Quint LE, Dunnick NR, Goodsitt M. Delayed enhanced CT for differentiation of benign from malignant adrenal masses. Radiology 1996; 200:737-742
6. Mayo-Smith WW, Boland GW, Noto RB, Lee MJ. State-of-the-art adrenal imaging. RadioGraphics 2001; 21:995-1012
7. Lee MJ, Mayo-Smith WW, Hahn PF, et al. Stateof-the-art MR imaging of the adrenal gland. RadioGraphics 1994; 14:1015-1029
8. Outwater EK, Siegelman ES, Radecki PD, Piccoli CW, Mitchell DG. Distinction between benign and malignant adrenal masses: value of T1-weighted chemical-shift MR imaging. AJR 1995; 165:579-583
9. Kim HK, Choi YS, Kim K, Kim J, Shim YM. Preoperative evaluation of adrenal lesions based on imaging studies and laparoscopic adrenalectomy in patients with otherwise operable lung cancer. Lung Cancer 2007; 58:342-347
10. Porte HL, Ernst OJ, Delebecq T, Metois D, Lemaitre LG, Wurtz AJ. Is computed tomography guided biopsy still necessary for the diagnosis of adrenal masses in patients with resectable nonsmall-cell lung cancer? Eur J Cardiothorac Surg 1999; 15:597-601
11. Boland GW, Goldberg MA, Lee MJ, et al. Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1995; 194:131-134
12. Maurea S, Mainolfi C, Wang H, et al. Positron emission tomography (PET) with fludeoxyglucose F 18 in the study of adrenal masses: comparison of benign and malignant lesions [in Italian]. Radiol Med (Torino) 1996; 92:782-787
13. Erasmus JJ, Patz EF Jr, McAdams HP, et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR 1997; 168: 1357-1360
14. Maurea S, Mainolfi C, Bazzicalupo L, et al. Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions. AJR 1999; 173:25-29
15. Gupta NC, Graeber GM, Tamim WJ, Rogers JS, Irisari L, Bishop HA. Clinical utility of PET-FDG imaging in differentiation of benign from malignant adrenal masses in lung cancer. Clin Lung Cancer 2001; 3:59-64
16. Yun M, Kim W, Alnafisi N, Lacorte L, Jang S, Alavi A. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med 2001; 42:1795-1799
17. Kumar R, Xiu Y, Yu JQ, et al. 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med 2004; 45:2058-2062
18. Blake MA, Slattery JM, Kalra MK, et al. Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy-initial experience. Radiology 2006; 238:970-977
19. Jana S, Zhang T, Milstein DM, Isasi CR, Blaufox MD. FDG-PET and CT characterization of adrenal lesions in cancer patients. Eur J Nucl Med Mol Imaging 2006; 33:29-35
20. Brink I, Schumacher T, Mix M, et al. Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer. Eur J Nucl Med Mol Imaging 2004; 31:1614-1620
21. Sung YM, Lee KS, Kim BT, et al. (18)F-FDG PET versus (18)F-FDG PET/CT for adrenal gland lesion characterization: a comparison of diagnostic efficacy in lung cancer patients. Korean J Radiol 2008; 9:19-28
22. Lee MJ, Hahn PF, Papanicolaou N, et al. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 1991; 179:415-418
23. Levi C, Gray JE, McCullough EC, Hattery RR. The unreliability of CT numbers as absolute values. AJR 1982; 139:443-447
24. Curry NS. Small renal masses (lesions smaller than 3 cm): imaging evaluation and management. AJR 1995; 164:355-362
25. Stadler A, Schima W, Prager G, et al. CT density measurements for characterization of adrenal tumors ex vivo: variability among three CT scanners. AJR 2004; 182:671-675
26. Hahn PF, Blake MA, Boland GW. Adrenal lesions: attenuation measurement differences between CT scanners. Radiology 2006; 240:458-463
27. Korobkin M, Lombardi TJ, Aisen AM, et al. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology 1995; 197:411-418
28. Outwater EK, Siegelman ES, Huang AB, Birnbaum BA. Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences. Radiology 1996; 200:749-752
29. Bagheri B, Maurer AH, Cone L, Doss M, Adler L. Characterization of the normal adrenal gland with 18F-FDG PET/CT. J Nucl Med 2004; 45:1340-1343
30. Metser U, Miller E, Lerman H, Lievshitz G, Avital S, Even-Sapir E. 18F-FDG PET/CT in the evaluation of adrenal masses. J Nucl Med 2006; 47:32-37
31. Caoili EM, Korobkin M, Brown RK, Mackie G, Shulkin BL. Differentiating adrenal adenomas from nonadenomas using (18)F-FDG PET/CT quantitative and qualitative evaluation. Acad Radiol 2007; 14:468-475
32. Mawlawi O, Podoloff DA, Kohlmyer S, et al. Performance characteristics of a newly developed PET/CT scanner using NEMA standards in 2D and 3D modes. J Nucl Med 2004; 45:1734-1742
33. Paulsen SD, Nghiem HV, Korobkin M, Caoili EM, Higgins EJ. Changing role of imaging-guided percutaneous biopsy of adrenal masses: evaluation of 50 adrenal biopsies. AJR 2004; 182:1033-1037